[Should Helicobacter pylori infection be considered in the management of dyspeptic patients?].
De Korwin
J D
JD
Service de Médecine D, CHU-Hôpital Central, Nancy.
D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D004382:Duodenitis / Q000150:complications; D004415:Dyspepsia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D005744:Gastric Acid / Q000378:metabolism; D005756:Gastritis / Q000150:complications; D005769:Gastrointestinal Motility; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology; D016480:Helicobacter pylori / Q000472:pathogenicity; D006801:Humans; D015995:Prevalence; D013997:Time Factors